1560dkk
-5,5 %
Date:2024-11-22Time:13:27:36Latest report:Q3-2024List:First NorthTicker:VIRO
Market Cap:121 mdkkEnterprise Value:119 mdkkNet Sales:4,20 mdkkEarnings:-13,2 mdkkEmployees:0ISIN:DK0061030574

Ratios

10-year key figure history for ViroGates turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for ViroGates with index and moving average MA50 and MA200.

Stockprice:15,60
MA50:8,45
MA200:7,19
Price/MA200:117,1 %
RSI (14):67,2
Price/MA50:84,6 %

Description

ViroGates AS is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.

Medical Equipment